Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Multicenter, Randomized, Double-blind, Active Controlled Study to Evaluate the Efficacy + Safety of IV + Oral Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Next Previous
Search
Trial Profile

A Phase 3, Multicenter, Randomized, Double-blind, Active Controlled Study to Evaluate the Efficacy + Safety of IV + Oral Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jul 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Delafloxacin (Primary) ; Delafloxacin (Primary) ; Aztreonam; Vancomycin
  • Indications Abscess; Bacterial skin diseases; Burn infections; Cellulitis; Erysipelas; Gram-negative infections; Skin and soft tissue infections; Wound infections
  • Focus Registrational; Therapeutic Use
  • Acronyms PROCEED
  • Sponsors Melinta Therapeutics

    • Most Recent Events

    • 09 Jul 2020 Results of post hoc analysis published in Menarini Ricerche Media Release.
    • 09 Jul 2020 According to a Menarini Ricerche media release, a post hoc analysis of pooled data from Phase 3 ABSSSI trials are included in the abstract book of the 30th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID
    • 08 Apr 2019 Results of pooled analysis from two phase III trials (NCT01984684, NCT01811732) assessing efficacy data across the Phase III ABSSSI studies, published in the Clinical Infectious Diseases.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top